viewOptiBiotix Health PLC

OptiBiotix sets launch date for weight management product

The commercial debut of SlimBiome Medical will be made at a conference called Vitafoods Europe 2019, being held in Geneva

SlimBiome is CE marked and helps reduce hunger pangs

OptiBiotix Health PLC (LON:OPTI) said it is launching its weight management product SlimBiome Medical on May 7.

Its commercial debut will be made at a conference called Vitafoods Europe 2019, being held in Geneva.

SlimBiome is CE marked and helps reduce hunger pangs. It can be used as part of a calorie-restricted diet to achieve sustainable weight loss.

“The launch allows us to continue to deliver on our sales strategy of building multiple revenue streams across various sales channels because it will help us accelerate the expansion our distribution and sales network in Europe and beyond and support recent distribution agreements we have established,” said Fred Narbel, managing director of OptiBiotix’s Prebiotics division.

Quick facts: OptiBiotix Health PLC

Price: 63.8848 GBX

Market: AIM
Market Cap: £54.58 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of OptiBiotix Health PLC named herein, including the promotion by the Company of OptiBiotix Health PLC in any Content on the Site, the Company...



Full interview: European healthcare broker sets 97p price target for...

OptiBiotix Health PLC's (LON:OPTI) Stephen O'Hara speaks to Proactive London following a research note whcih has been published on the company by Goetz partners - which has set OPTI a price target of 97p. O'Hara says Goetz partners are a leading European Investment Bank and broking firm and...

on 11/9/19

2 min read